findmyKOL
Clinical trialNCT00768729CompletedPhase 1Interventional

Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment7ImmunosuppressionKidney Failure, ChronicKidney Transplantation
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Kidney transplantation is widely considered to be the treatment of choice for children with End Stage Renal Disease (ESRD). The purpose of this study is to determine the safety of sirolimus monotherapy for long-term immunosuppression in children and adolescents after kidney transplantation.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Children'S Hospital of Central California

    Madera, California, United States

  • Ucsf Children'S Hospital

    San Francisco, California, United States

  • Children'S Hospital, Boston

    Boston, Massachusetts, United States

  • Children'S Hospital, Philadelphia

    Philadelphia, Pennsylvania, United States

  • Children'S Hospital and Regional Medical Center, Seattle

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

MMF or AzathioprineSirolimus →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2009
Primary completion
31 Dec 2012
Completion
31 Dec 2012
Last update posted
15 Feb 2013
Registered enrollment
7
Registry id
NCT00768729
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.